Observational Study of Pain Reduction in Late-Stage Cancer Patients Who Are Receiving Low-Dose Chemotherapy
This trial is active, not recruiting.
|Sponsor||Cure Cancer Worldwide, LLC|
|Start date||May 2015|
|End date||August 2020|
|Trial size||300 participants|
|Trial identifier||NCT02443675, C4 OS-1|
Observational Study of Pain Reduction in Late Stage Cancer Patients Receiving Low-Dose Chemotherapy
Pain Level Self Assessment
time frame: 5 years
Male or female participants of any age.
Inclusion Criteria: - Patient requests to be included in this study Exclusion Criteria: - Patient does not request to be included in this study
|Official title||Observational Study of Pain Reduction in Late-Stage Cancer Patients Who Are Receiving Low-Dose Chemotherapy|
|Description||Observational Study of Pain Reduction in Late Stage Cancer Patients who are Receiving Low-Dose Chemotherapy (Metabolic Targeting)|
Call for more information